Birdwatch Note
2023-10-16 03:46:30 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
There is no evidence that president Trump uses illegal drugs l. This is a libelous tweet and poster should be suspended https://www.newsweek.com/all-presidents-meds-trumps-prescription-drugs-include-statin-baby-aspirin-and-779972
Written by D197390DDDE94D7E4032E7CDDB62AA01B0083E32791A8E033C9CABCE29B75503
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1713620739926970691
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1713763322536091805
- noteId - 1713763322536091805
- participantId -
- noteAuthorParticipantId - D197390DDDE94D7E4032E7CDDB62AA01B0083E32791A8E033C9CABCE29B75503 Participant Details
- createdAtMillis - 1697427990931
- tweetId - 1713620739926970691
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- There is no evidence that president Trump uses illegal drugs l. This is a libelous tweet and poster should be suspended https://www.newsweek.com/all-presidents-meds-trumps-prescription-drugs-include-statin-baby-aspirin-and-779972
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-10-16 03:46:30 UTC (1697427990931) |
1969-12-31 23:59:59 UTC (-1) |
2023-10-18 02:53:36 UTC (1697597616809) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
rated at | rated by | |
2023-10-16 16:26:51 -0500 | Rating Details | |
2023-10-16 11:18:21 -0500 | Rating Details | |
2023-10-16 10:26:58 -0500 | Rating Details | |
2023-10-16 09:30:13 -0500 | Rating Details | |
2023-10-16 09:21:57 -0500 | Rating Details | |
2023-10-16 06:05:47 -0500 | Rating Details | |
2023-10-16 01:35:53 -0500 | Rating Details | |
2023-10-16 01:01:41 -0500 | Rating Details | |
2023-10-16 00:48:51 -0500 | Rating Details | |
2023-10-16 00:25:13 -0500 | Rating Details | |
2023-10-15 23:11:19 -0500 | Rating Details | |
2023-10-15 23:08:42 -0500 | Rating Details | |
2023-10-22 17:18:30 -0500 | Rating Details | |
2023-10-22 16:38:06 -0500 | Rating Details | |
2023-10-22 16:23:31 -0500 | Rating Details | |
2023-10-22 22:58:34 -0500 | Rating Details | |
2023-10-24 09:01:51 -0500 | Rating Details | |
2023-10-24 07:20:40 -0500 | Rating Details | |
2023-10-23 01:01:04 -0500 | Rating Details | |
2023-10-22 23:42:37 -0500 | Rating Details | |
2023-10-22 23:25:46 -0500 | Rating Details | |
2023-10-22 18:23:14 -0500 | Rating Details | |
2023-10-22 16:26:02 -0500 | Rating Details | |
2023-10-22 11:37:32 -0500 | Rating Details | |
2023-10-22 11:27:50 -0500 | Rating Details | |
2023-10-22 11:22:23 -0500 | Rating Details | |
2023-10-22 10:41:33 -0500 | Rating Details | |
2023-10-22 06:57:34 -0500 | Rating Details | |
2023-10-19 02:05:35 -0500 | Rating Details | |
2024-05-15 20:15:49 -0500 | Rating Details | |
2024-05-18 14:00:49 -0500 | Rating Details | |
2024-05-18 01:24:04 -0500 | Rating Details | |
2024-05-15 23:06:10 -0500 | Rating Details | |
2024-06-06 11:35:27 -0500 | Rating Details | |
2024-06-06 21:45:50 -0500 | Rating Details | |
2024-06-06 21:17:07 -0500 | Rating Details | |
2024-06-15 19:01:06 -0500 | Rating Details | |
2024-06-12 21:06:31 -0500 | Rating Details | |
2024-06-12 21:25:51 -0500 | Rating Details |